دورية أكاديمية
6007 ORAL MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a
| العنوان: | 6007 ORAL MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a |
|---|---|
| المؤلفون: | Tinhofer, I., Gryshchenko, I., Stoecher, M., Hofbauer, S., Daniel, P.T., Greil, R. |
| المصدر: | In EJC Supplements 2007 5(4):347-347 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 13596349 |
|---|---|
| DOI: | 10.1016/S1359-6349(07)71298-3 |